Flow cytometry analysis of human CD45+ cells in the bone marrow and spleen revealed a substantial reduction in human CML tumor blast following combined treatment with Chi and IM, compared to either treatment alone (Fig. 7e, f). Here, PTPRC is linked to neoplasm.